FDA Inspection 1046744 — Vanderbilt University Medical Center

Vanderbilt University Medical Center — FEI 1071195

The FDA completed an inspection of Vanderbilt University Medical Center on Mar 26, 2018 in Nashville, TN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 26, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Nashville, TN (United States)